About Uppsala University Hospital; Department of Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Alligator Bioscience AB
2
Hoffmann-La Roche
2
Uppsala University
2
Endocyte
1
ITM Solucin GmbH
1
Lund University Hospital
1
Mendus
1
Odense University Hospital
1
Puma Biotechnology, Inc.
1
Repos Pharma
1
Clinical Trials at Uppsala University Hospital; Department of Oncology
During the past decade, Uppsala University Hospital; Department of Oncology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer
2004-02-01
2008-10-01
Completed
116
Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.
2009-09-01
2017-08-01
Completed
51
A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer
2012-02-01
2013-12-01
Completed
12
A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting
2013-03-29
2019-12-09
Completed
621
CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.
2014-04-01
2017-05-31
Completed
15
CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy
2017-09-18
2021-08-19
Completed
24
A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
2017-10-25
2022-04-07
Completed
619
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Uppsala University Hospital; Department of Oncology" #1 sponsor was "Alligator Bioscience AB" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials
sponsored, "Uppsala University" with 2 trials sponsored, "Endocyte" with 1 trials sponsored and "ITM Solucin GmbH"
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Uppsala University Hospital; Department of Oncology"
#1 collaborator was "Uppsala University Hospital" with 3 trials as a collaborator, "AFA Insurance" with 2 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Karolinska University Hospital" with 1 trials as a collaborator and "Mundipharma Pte Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Uppsala University Hospital; Department of Oncology
According to Clinical.Site data, the most researched conditions in "Uppsala University Hospital; Department of Oncology" are
"Neoplasms" (2 trials), "B Cell Leukemia" (1 trials), "B Cell Lymphoma" (1 trials), "B-Cell Lymphoma" (1 trials) and "B-cell Leukemia" (1 trials). Many other conditions were trialed in "Uppsala University Hospital; Department of Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Uppsala University Hospital; Department of Oncology
Most popular intervention types in "Uppsala University Hospital; Department of Oncology" are "Drug" (8 trials), "Biological" (5 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT" (1 trials), "177Lu-PSMA-617" (1 trials), "ADC-1013" (1 trials), "ATOR-1017" (1 trials) and "Amino-Acid Solution" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Uppsala University Hospital; Department of Oncology
The vast majority of trials in "Uppsala University Hospital; Department of Oncology" are
12 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Uppsala University Hospital; Department of Oncology
Currently, there are NaN active trials in "Uppsala University Hospital; Department of Oncology".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Uppsala University Hospital; Department of Oncology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Uppsala University Hospital; Department of Oncology, 6 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".